These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23172908)

  • 1. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models.
    Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA
    Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
    Bates EA; Victor M; Jones AK; Shi Y; Hart AC
    J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS.
    Chitramuthu BP; Kay DG; Bateman A; Bennett HP
    PLoS One; 2017; 12(3):e0174784. PubMed ID: 28358904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
    Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
    Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
    Nguyen T; Hamby A; Massa SM
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11840-5. PubMed ID: 16087879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin.
    Wang H; Lim PJ; Yin C; Rieckher M; Vogel BE; Monteiro MJ
    Hum Mol Genet; 2006 Mar; 15(6):1025-41. PubMed ID: 16461334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans.
    Vaccaro A; Tauffenberger A; Aggad D; Rouleau G; Drapeau P; Parker JA
    PLoS One; 2012; 7(2):e31321. PubMed ID: 22363618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)-binding protein 1 in Huntington's disease.
    Mori S; Honda H; Ishii T; Yoshimura M; Sasagasako N; Suzuki SO; Taniwaki T; Iwaki T
    Neuropathology; 2019 Oct; 39(5):358-367. PubMed ID: 31599037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model.
    Nishimura Y; Yalgin C; Akimoto S; Doumanis J; Sasajima R; Nukina N; Miyakawa H; Moore AW; Morimoto T
    J Neurogenet; 2010 Dec; 24(4):194-206. PubMed ID: 21087194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes.
    Machiela E; Dues DJ; Senchuk MM; Van Raamsdonk JM
    Neurobiol Dis; 2016 Dec; 96():1-11. PubMed ID: 27544481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH; Li XJ
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.
    Schwab C; Arai T; Hasegawa M; Yu S; McGeer PL
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1159-65. PubMed ID: 19018245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
    Truant R; Atwal RS; Burtnik A
    Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells.
    Colombrita C; Onesto E; Megiorni F; Pizzuti A; Baralle FE; Buratti E; Silani V; Ratti A
    J Biol Chem; 2012 May; 287(19):15635-47. PubMed ID: 22427648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
    Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
    Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels.
    Salazar DA; Butler VJ; Argouarch AR; Hsu TY; Mason A; Nakamura A; McCurdy H; Cox D; Ng R; Pan G; Seeley WW; Miller BL; Kao AW
    J Neurosci; 2015 Jun; 35(25):9315-28. PubMed ID: 26109656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
    Lee WC; Yoshihara M; Littleton JT
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.